| Literature DB >> 33100770 |
Kamrul Ahsan1, Sariful Hasan1, Shahidul Islam Khan1, Naznin Zaman2, Saif Salman Almasri3, Nazmin Ahmed4, Bipin Chaurasia5.
Abstract
BACKGROUND: Treatment option of postoperative discitis (POD) is either conservative or operative, but till date, there are no established validated protocols of the treatment of postoperative lumbar discitis. AIM: The aim of this study was to assess the outcome of conservative versus operative management of POD following single-level lumbar discectomy.Entities:
Keywords: Conservative and operative management; lumbar; postoperative discitis
Year: 2020 PMID: 33100770 PMCID: PMC7546051 DOI: 10.4103/jcvjs.JCVJS_111_20
Source DB: PubMed Journal: J Craniovertebr Junction Spine ISSN: 0974-8237
Figure 1(a and b) T1 and T2 sagittal and (c) axial images of postoperative spondylodiscitis. (a and b) Acute stage with altered vertebral marrow signal intensity and associated endplate erosion. (d and e) Partially healed stage with minimum residual paradiscal vertebral marrow edema after 14 weeks. Conservative treatment (f) plain X-ray shows narrowing of disc space with healing after 2 years
The modified criteria of Kirkaldy–Willis for the functional outcome
| Grade | Description |
|---|---|
| Excellent | The patient has returned to his routine work and other activities with little or no complaint |
| Good | The patient has returned to his routine work but may have some restriction in other activities and may on occasion after heavy work have recurrent back pain requiring rest for a few days |
| Fair | The patient has to reduce his working capacity, take a lighter job or work part-time, and occasionally have a recurrence of pain requiring absence from work for 1–2 weeks, once or twice a year |
| Poor | The patient does not return to work |
Demographics in patients with conservative and operative management groups
| Characteristics | Conservative, Group A ( | Operative, Group B ( | |
|---|---|---|---|
| Mean age (years) | 42.53±10.40 (range, 26-65) | 45.95±11.90 (range, 26-65) | 0.804ns |
| Sex | |||
| Male | 12 (63.2) | 14 (73.7) | 0.485ns |
| Female | 7 (36.8) | 5 (26.3) | |
| Occupation | |||
| Service holder | 5 (26.3) | 5 (26.3) | 0.804ns |
| Businessman | 7 (36.8) | 6 (31.6) | |
| Homemakers | 3 (15.8) | 4 (21.1) | |
| Others | 4 (21.1) | 4 (21.1) | |
| Clinical presentation | |||
| Back pain | 19 (100) | 19 (100) | 1.000ns |
| Leg pain | 8 (42.10) | 10 (52.6) | 0.516ns |
| SLRT | 12 (63.2) | 12 (63.2) | 1.000ns |
| Muscle spasm | 12 (63.2) | 14 (73.7) | 0.483ns |
| Pseudo-Gower sign | 7 (36.84) | 8 (42.10) | 0.482ns |
| The pain-free interval of development of symptoms of discitis | |||
| Within 1-2 weeks | 3 (15.8) | 2 (10.5) | 0.631ns |
| >2-8 weeks | 16 (84.2) | 17 (89.5) | |
| Involved level | |||
| L3-L4 | 3 (15.8) | 2 (10.5) | 0.780ns |
| L4-L5 | 12 (63.2) | 14 (73.7) | |
| L5-S1 | 4 (21.1) | 3 (15.8) | |
| Risk factors | |||
| Smoking | 5 (26.32) | 5 (26.32) | 0.931ns |
| Obesity | 6 (31.58) | 8 (42.10) | |
| DM | 7 (36.84) | 6 (31.58) | |
| Malnourished | 1 (5.26) | 0 | |
| Mean duration of symptoms (days) | 8.8 (range, 5-21) | 9 0.5 (range, 7-21) | |
| Mean follow-up (months) | 14.8 (range, 12-24) | 13.6 (range, 12-24) |
SLRT - Straight leg raising test; DM - Diabetes mellitus
Inflammatory markers (blood culture, aspiration, and tissue biopsy in Group A and Group B)
| Blood parameters | Group A ( | Group B ( | |
|---|---|---|---|
| Mean ESR (mm in the 1st h) | |||
| Pretreatment | 60.32±18.02 (41-91) | 62.11±17.23 (41-74) | 0.756ns |
| Posttreatment | |||
| 2 weeks | 52.00±14.31 | 30.63±6.57 | <0.001* |
| 1 month | 40.68±9.48 | 25.42±3.91 | <0.001* |
| 3 months | 28.00±4.18 | 20.89±5.41 | <0.001* |
| 6 months | 17.42±3.29 (12-26) | 15.16±3.85 (12-22) | 0.059ns |
| 12 months | 14.37±2.29 | 12.68±1.94 | 0.020 |
| Pre versus Post -treatment p value at 12 months ( | <0.001* | <0.001* | |
| Mean CRP (mg/L) | |||
| Pretreatment | 70.68±19.82 (39-93) | 72.84±20.93 (49-90) | 0.746ns |
| Posttreatment | |||
| 2 weeks | 60.47±11.48 | 32.37±8.47 | <0.001* |
| 1 month | 42.18±7.82 | 20.89±8.92 | <0.001* |
| 3 months | 23.89±3.36 | 13.37±3.40 | <0.001* |
| 6 months | 12.16±3.35 (7-25) | 10.16±2.93 (7-16) | 0.058ns |
| 12 months | 8.10±2.97 | 6.21±1.65 | 0.020 |
| Pre versus post-treatment p value at 12 months ( | <0.001* | <0.001* | |
| Blood culture positive total of 18 patients (47.37%) | 10 (52.63%) | 8 (42.11%) | |
| | 6 (31.58%) | 5 (26.32%) | |
| | 3 (15.79%) | 2 (10.53%) | |
| | 1 (5.26%) | 1 (5.26%) | |
| Disc space aspiration, 22 cases (57.89%) positive | 12 (63.16%) | 10 (52.63%) | |
| | 7 (36.84%) | 6 (31.58%) | |
| | 4 (21.05%) | 3 (15.79%) | |
| | 1 (5.26%) | 1 (5.26%) | |
| Tissue biopsy (aspiration and post operative tissue/culture/gram staining) | Mixture of inflammatory cells | Mixture of inflammatory cells Growth - 6 cases | |
| Total isolation of organism 26 cases | 12 (63.16%) cases | 14 (73.68%) cases |
nsNot significant, *Significant. S. aureus - Staphylococcus aureus; S. epidermidis - Staphylococcus epidermidis; E. coli - Escherichia coli; ESR - Erythrocyte sedimentation rate; CRP - C-reactive protein
Figure 2(a and b) T1 and T2 sagittal and (c) axial images of postoperative discitis with altered vertebral marrow signal intensity and associated endplate erosion. (d and e) transforaminal lumbar interbody fusion with titanium cage with bone graft and stabilized by pedicle screws, follow-up at 6 months, and 15 months with union
Clinical and functional outcome assessment by VAS, JOA and modified criteria of Kirkaldy-Willis
| Clinical criteria | Group A ( | Group B ( | ||||
|---|---|---|---|---|---|---|
| Pretreatment | Posttreatment after 1 year | Pretreatment | Posttreatment after 1 year | |||
| VAS for back pain | 7.16±1.98 | 2.47±1.93 | 0.001s | 7.53±1.73 | 1.32±1.59 | 0.001s |
| Low back pain | 0.26±0.45 | 1.95±0.71 | <0.001s | 0.42±0.51 | 2.05±0.62 | <0.001s |
| Leg pain and or tingling | 0.26±0.45 | 1.95±0.71 | <0.001s | 0.32±0.48 | 1.95±0.71 | <0.001s |
| Ability to walk | 0.26±0.45 | 1.95±0.71 | <0.001s | 0.26±0.45 | 2.11±0.74 | <0.001s |
| SLRT | 0.26±0.45 | 1.42±0.51 | <0.001s | 0.26±0.45 | 1.53±0.51 | <0.001s |
| Sensory disturbance | 0.84±0.37 | 1.63±0.50 | <0.001s | 0.74±0.45 | 1.79±0.42 | <0.001s |
| Motor disturbance | 0.26±0.45 | 1.74±0.45 | <0.001s | 0.37±0.50 | 1.68±0.48 | <0.001s |
| Restriction of daily activities | 7.26±0.81 | 12.37±1.17 | <0.001s | 7.26±0.81 | 12.84±1.17 | <0.001s |
| Urinary bladder function | −0.63±1.26 | 0.00±0.00 | 0.042s | −0.47±1.12 | 0.00±0.00 | 0.083ns |
| Total JOA score* | 8.79±3.03 | 23.00±2.87 | <0.001s | 9.16±3.08 | 23.95±2.72 | <0.001s |
| Excellent | 6 (31.58) | 9 (47.4) | 0.613ns | |||
| Good | 8 (42.11) | 7 (36.8) | ||||
| Fair | 4 (21.05) | 3 (15.8) | ||||
| Poor | 1 (5.26) | 0 | ||||
| Satisfactory | 14 (73.69) | 16 (84.2) | 0.692ns | |||
| Unsatisfactory | 5 (26.31) | 3 (15.8) | ||||
sSignificant; nsNot significant. VAS - Visual Analog Scale; JOA - Japanese Orthopedic Association Score; CI - Confidence interval
Surgical data and complications in Group A and Group B
| Characteristics | Conservative Group A ( | Operative Group B ( | |
|---|---|---|---|
| Mean operative time (min) | 135 (range 90-180) | ||
| Length of hospitalization (days) | 52.32±6.51 (45-65) | 30.11±4.41 (25-37) | 0.001 |
| Length of antibiotic treatment (I/V + oral) (days) | 78.00±5.35 (69-92) | 40.15±3.48 (34-50) | 0.001 |
| Need for blood transfusion | 6 (31.58%) patients | 12 (63.16%) patients | |
| No complications | 12 (63.2%) | 17 (89.5%) | 0.124 |
| Complications | 7 (36.84) | 2 (10.53%) | 0.124 |
| Wound infection | 1 (5.26%) | 1 (5.26%) | |
| Urinary incontinence | 1 (5.26%) | 0 | |
| Persisting pain | 1 (5.26%) | 0 | |
| Others due to antibiotics, e.g., allergic reaction | |||
| Phlebitis | 4 (21.05%) | 1 (5.26%) | |
| Total cost of the procedure | Taka 80,000 ($940) | Taka 115,000 ($1352) | <0.001 |
I/V - Intravenous